References
- Abdellatif, K.R., Belal, A., and Omar, H.A., 2013. Design, synthesis and biological evaluation of novel triaryl (Z)-olefins as tamoxifen analogues. Bioorganic and medicinal chemistry letters, 23 (17), 4960–4963.
- Abdellatif, K.R., et al., 2011. Triaryl (Z)-olefins suitable for radiolabeling with iodine-124 or fluorine-18 radionuclides for positron emission tomography imaging of estrogen positive breast tumors. Bioorganic and medicinal chemistry letters, 21 (4), 1195–1198.
- Abdelrahman, A.A., et al., 2015. Modeling, optimization, and in vitro corneal permeation of chitosan-lomefloxacin HCl nanosuspension intended for ophthalmic delivery. Journal of pharmaceutical innovation, 10 (3), 254–268.
- Abhinav, K., et al., 2011. Review on niosomes as novel drug delivery system. International research journal of pharmacy, 2 (5), 61–65.
- Burstein, H.J., et al., 2014. Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update. Journal of clinical oncology, 32 (21), 2255–2269.
- Feldman, J.P., et al., 2009. A mathematical model for tumor volume evaluation using two-dimensions. Journal of applied quantitative methods, 4 (4), 455–462.
- Fratoddi, I., et al., 2014. Gold nanoparticles and gold nanoparticle-conjugates for delivery of therapeutic molecules. Progress and challenges. Journal of materials chemistry B, 2 (27), 4204–4220.
- Frens, G., 1973. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature, 241 (105), 20–22.
- Ganguly, S., and Dash, A.K., 2004. A novel in situ gel for sustained drug delivery and targeting. International journal of pharmaceutics, 276 (1–2), 83–92.
- Gao, S., and Singh, J., 1998. In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes. Journal of controlled release, 51 (2–3), 193–199.
- Gargiulo, S., et al., 2012. Mice anesthesia, analgesia, and care, Part I: anesthetic considerations in preclinical research. ILAR journal, 53 (1), E55–E69.
- Guinedi, A.S., et al., 2005. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. International journal of pharmaceutics, 306 (1–2), 71–82.
- Hao, Y.-M., and Li, K. A., 2011. Entrapment and release difference resulting from hydrogen bonding interactions in niosome. International journal of pharmaceutics, 403 (1–2), 245–253.
- Hao, Y., et al., 2002. Studies on a high encapsulation of colchicine by a niosome system. International journal of pharmaceutics, 244 (1–2), 73–80.
- Kumar, G.P., and Rajeshwarrao, P., 2011. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta pharmaceutica sinica B, 1 (4), 208–219.
- Mali, D.B., et al., 2013. In-vivo study of tissue distribution of tamoxifen loaded stealth liposomes in mammary tumor. Journal of cell and tissue research, 13 (1), 3451.
- Manosroi, A., et al., 2003. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids and Surfaces B: Biointerfaces, 30 (1–2), 129–138.
- Moawad, F. A., Ali, A. A., and Salem, H. F., 2017. Nanotransfersomes-loaded thermosensitive in situ gel as a rectal delivery system of tizanidine HCl: preparation, in vitro and in vivo performance. Drug delivery, 24 (1), 252–260.
- Motwani, S.K., et al., 2008. Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. European journal of pharmaceutics and biopharmaceutics, 68 (3), 513–525.
- Nasr, M., et al., 2008. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. Journal of microencapsulation, 25 (7), 499–512.
- Nasseri, B., 2005. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. International journal of pharmaceutics, 300 (1–2), 95–101.
- Putt, F., 1954. Histopathologic technic and practical histochemistry. The yale journal of biology and medicine, 27 (1), 73.
- Salem, H.F., et al., 2015. Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study. Drug design, development and therapy, 9, 3705.
- Salem, H.F., 2010. Sustained-release progesterone nanosuspension following intramuscular injection in ovariectomized rats. International journal of nanomedicine, 5, 943.
- Salem, H.F., Ahmed, S.M., and Omar, M.M., 2016. Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery. Drug design, development and therapy, 10, 277.
- Sanceau, J., et al., 2002. Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide. Oncogene, 21 (50), 7700.
- Sandeep, K., 2009. Span-60 niosomal oral suspension of fluconazole: formulation and in vitro evaluation. Asian journal of pharmaceutical research and health care, 1 (2), 142–156.
- Sankhyan, A., and Pawar, P., 2012. Recent trends in niosome as vesicular drug delivery system. Journal of applied pharmaceutical science, 2 (6), 20–32.
- Shaker, D.S., Nasr, M., and Mostafa, M., 2013. Bioavailability and hypocholesterolemic effect of proniosomal simvastatin for transdermal delivery. International Journal of pharmacy and pharmaceutical sciences, 5 (4), 344–351.
- Shaker, D.S., Shaker, M.A., and Hanafy, M.S., 2015. Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes. International journal of pharmaceutics, 493 (1–2), 285–294.
- Shaker, D.S., et al., 2016. In situ thermosensitive Tamoxifen citrate loaded hydrogels: an effective tool in breast cancer loco-regional therapy. Journal of drug delivery science and technology, 35, 155–164.
- Silva, L.A., et al., 2006. Sunflower seed oil-enriched product can inhibit Ehrlich solid tumor growth in mice. Chemotherapy, 52 (2), 91–94.